Abstract
Arterial and venous thromboembolic events occur commonly after surgery and cause potentially preventable morbidity and mortality. Current evidence-based management strategies have significantly reduced the incidence of venous thromboembolism, although there is room for further improvements with the administration of safer antithrombotic agents and the implementation of specific guidelines coupled with rigorous clinical audits.
Novel antithrombotic agents (oral formulations of direct thrombin inhibitors or inhibitors of factor Xa) offer the advantages of more predictable biological responses, low potential for drug or dietary interactions, and greater specificity, with no need for routine patient monitoring. Further studies are needed to assess their risk–benefit and cost–utility compared to classic thromboprophylaxis.
The plethora of official recommendations can be confusing, if not overwhelming. In this review, we summarize the most effective methods of thromboprophylaxis available, taking into account the risks of bleeding and venous thromboembolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
References
Akl EA, Terrenato I et al (2008) Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Arch Intern Med 168(12):1261–1269
Astrup T (1958) The haemostatic balance. Thromb Diath Haemorrh 2(3–4):347–357
Bahl V, Hu M, Henke PK (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 251(2):344–350
Baser O, Supina D et al (2011) Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery. Curr Med Res Opin 27(2):423–429
Bauer KA et al (2011) Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. J Thromb Haemost 9(Suppl 1):12–19
Becattini C, Agnelli G et al (2012) Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 8(1):108–115
Bikdeli B, Sharif-Kashani B (2012) Prophylaxis for venous thromboembolism: a great global divide between expert guidelines and clinical practice? Semin Thromb Hemost 38(2):144–155
Budnitz DS, Pollock DA et al (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296(15):1858–1866
Burness CB, McKeage K (2012) Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery. Drugs 72(7):963–986
Caprini JA, Arcelus JI et al (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 38(2 Suppl 5):12–19
Carlquist JF, Anderson JL (2011) Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Circulation 124(23):2554–2559
Chee YL, Crawford JC et al (2008) Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 140(5):496–504
Cohen AT, Alikhan R et al (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94(4):750–759
Cohen AT, Tapson VF et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371(9610):387–394
Darvall K, Bradbury A (2012) Pathways for venous thromboembolic prophylaxis in medical and surgical patients. Phlebology 27(Suppl 2):33–42
Deitelzweig SB, McKean SC et al (2008) Prevention of venous thromboembolism in the orthopedic surgery patient. Cleve Clin J Med 75(Suppl 3):S27–S36
Delis KT, Knaggs AL et al (2004) Effects of epidural-and-general anesthesia combined versus general anesthesia alone on the venous hemodynamics of the lower limb. A randomized study. Thromb Haemost 92(5):1003–1011
Dobesh PP (2009) Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy 29(8):943–953
Douketis JD, Spyropoulos AC et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e326S–e350S
Duran A, Sengupta A et al (2012) Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer’s perspective. Pharmacoeconomics 30(2):87–101
Dzik WS (2012) Reversal of drug-induced anticoagulation: old solutions and new problems. Transfusion 52(Suppl 1):45S–55S
Eerenberg ES, Kamphuisen PW et al (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124(14):1573–1579
Eriksson BI, Ekman S et al (1997a) Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement. J Bone Joint Surg Am 79(3):326–333
Eriksson BI, Wille-Jorgensen P et al (1997b) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337(19):1329–1335
Eriksson BI, Quinlan DJ et al (2009) Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development. Clin Pharmacokinet 48(1):1–22
Falck-Ytter Y, Francis CW et al (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e278S–e325S
Fareed J, Thethi I et al (2012) Old versus new oral anticoagulants: focus on pharmacology. Annu Rev Pharmacol Toxicol 52:79–99
Galante M, Languasco A et al (2012) Venous thromboprophylaxis in general surgery ward admissions: strategies for improvement. Int J Qual Health Care 24(6):649–656
Geerts WH, Bergqvist D et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S–453S
Geraghty AJ, Welch K (2011) Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev (6):CD000536
Gogarten W, Vandermeulen E et al (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 27(12):999–1015
Gomez-Outes A, Terleira-Fernandez AI et al (2012) Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ 344:e3675
Gould MK, Garcia DA et al (2012a) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e277S
Gould MK, Garcia DA et al (2012b) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e277S
Graetz TJ, Tellor BR et al (2011) Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis. Expert Rev Cardiovasc Ther 9(9):1101–1109
Greinacher A, Warkentin TE (2008) The direct thrombin inhibitor hirudin. Thromb Haemost 99(5):819–829
Hahnenkamp K, Theilmeier G et al (2002) The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesth Analg 94(6):1441–1447
Hamilton MG, Yee WH et al (2011) Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery 68(3):571–581
Heron R, Davie A et al (2001) Interrater reliability of the Glasgow Coma Scale scoring among nurses in sub-specialties of critical care. Aust Crit Care 14(3):100–105
Hirsh J, Warkentin TE et al (2001) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119(1 Suppl):64S–94S
Horlocker TT, Wedel DJ et al (2010) Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 35(1):64–101
Huber O, Bounameaux H et al (1992) Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 127(3):310–313
Januel JM, Chen G et al (2012) Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 307(3):294–303
Junqueira DR, Perini E et al (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev (9):CD007557
Kaatz S, Kouides PA et al (2012) Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol 87(Suppl 1):S141–S145
Kakkar VV, Spindler J et al (1972) Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery: a double-blind, randomised trial. Lancet 300(7768):101–106
Kakkar AK, Brenner B et al (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 372(9632):31–39
Kakkos SK, Caprini JA et al (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev (4):CD005258
Kakkos SK, Warwick D et al (2012) Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery. J Bone Joint Surg Br 94(6):729–734
Kanchanabat B, Stapanavatr W et al (2011) Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg 98(10):1356–1364
Keeling D, Baglin T et al (2011) Guidelines on oral anticoagulation with warfarin – fourth edition. Br J Haematol 154(3):311–324
Khaw FM, Moran CG et al (1993) The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation. J Bone Joint Surg Br 75(6):940–941
Kucher N, Koo S et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352(10):969–977
Mauermann WJ, Shilling AM et al (2006) A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 103(4):1018–1025
Mismetti P, Laporte S et al (2004) Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost 2(7):1058–1070
Morris RJ, Woodcock JP (2010) Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg 251(3):393–396
Muntz JE, Michota FA (2010) Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors. Am J Surg 199(1 Suppl):S11–S20
Muntz J, Scott DA et al (2004) Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care 20(4):405–414
Nagler M, Haslauer M et al (2012) Fondaparinux – data on efficacy and safety in special situations. Thromb Res 129(4):407–417
Neumann I, Rada G et al (2012) Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med 156(10):710–719
Oger E (2000) Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83(5):657–660
Ollendorf DA, Vera-Llonch M et al (2002) Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm 59(18):1750–1754
Pengo V, Lensing AW et al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350(22):2257–2264
Petitou M, Nancy-Portebois V et al (2009) From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Thromb Haemost 102(5):804–810
Phillips SM, Gallagher M et al (2008) Use graduated compression stockings postoperatively to prevent deep vein thrombosis. BMJ 336(7650):943–944
Poultsides LA, GonzalezDellaValle A et al (2012) Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br 94(1):113–121
Rahn DD, Mamik MM et al (2011) Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gynecol 118(5):1111–1125
Rasmussen MS, Jorgensen LN et al (2009) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev (1):CD004318
Roderick P, Ferris G et al (2005) Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 9(49):iii–iv, ix–x, 1–78
Rogers SO Jr, Kilaru RK et al (2007) Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 204(6):1211–1221
Salazar CA, Malaga G et al (2010) Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Database Syst Rev (4):CD005981
Schenone M, Furie BC et al (2004) The blood coagulation cascade. Curr Opin Hematol 11(4):272–277
Schulman S, Majeed A (2012) The oral thrombin inhibitor dabigatran: strengths and weaknesses. Semin Thromb Hemost 38(1):7–15
Shantsila E, Lip GY et al (2009) Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest 135(6):1651–1664
Stringer MD, Steadman CA et al (1989) Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br 71(3):492–497
Tanaka KA, Key NS et al (2009) Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 108(5):1433–1446
Turpie AG (1998) Pharmacology of the low-molecular-weight heparins. Am Heart J 135(6 Pt 3 Su):S329–S335
Turpie AGG, Bauer KA et al (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162(16):1833–1840
Urbankova J, Quiroz R et al (2005) Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost 94(6):1181–1185
Van De Car DA, Rao SV et al (2010) Bivalirudin: a review of the pharmacology and clinical application. Expert Rev Cardiovasc Ther 8(12):1673–1681
Weinz C, Schwarz T et al (2009) Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metab Dispos 37(5):1056–1064
White RH, Zhou H et al (2003) Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90(3):446–455
White RH, Chew H et al (2007) Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk? Thromb Res 120(Suppl 2):S29–S40
Wilde MI, Markham A (1997) Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs 54(6):903–924
Windisch C, Kolb W et al (2011) Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. Int Orthop 35(7):995–1000
Wolberg AS, Aleman MM et al (2012) Procoagulant activity in hemostasis and thrombosis: Virchow’s triad revisited. Anesth Analg 114(2):275–285
Wozniak M, Kruit A et al (2012) Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol. Transfus Apher Sci 46(3):309–314
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Aldenkortt, M., Licker, M. (2015). Perioperative Thromboprophylaxis. In: Marcucci, C., Schoettker, P. (eds) Perioperative Hemostasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55004-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-55004-1_23
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55003-4
Online ISBN: 978-3-642-55004-1
eBook Packages: MedicineMedicine (R0)